Skip to main content
Clinical Trials/JPRN-UMIN000027091
JPRN-UMIN000027091
Recruiting
未知

Identification of biomarker and clarification of resistance mechanism in immune checkpoint inhibitor therapy - IBIC

Kanagawa Cancer Center Research Institute0 sites560 target enrollmentApril 24, 2017

Overview

Phase
未知
Intervention
Not specified
Conditions
on-small cell lung cancer Kidney cancer Malignant melanoma Classical Hodgkin&#39
Sponsor
Kanagawa Cancer Center Research Institute
Enrollment
560
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
April 24, 2017
End Date
March 31, 2024
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Kanagawa Cancer Center Research Institute

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • (1\) Minor (2\) Difficult to obtain consent

Outcomes

Primary Outcomes

Not specified

Similar Trials